Decreased levels of serum platelet-activating factor acetylhydrolase in patients with rheumatic diseases

• Autori principali: P. Vergne (Autore), V. Praloran (Autore), R. Treves (Autore), Y. Denizot (Autore)
• Natura: Libro
• Pubblicazione: Hindawi Limited, 1997-01-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

PAF is a potent inflammatory compound known to stimulate the release of various cytokines involved in rheumatic diseases. Elevated blood PAF levels are reported in these patients. We report that serum PAF acetylhydrolase activity (AHA) levels are decreased in patients with rheumatoid arthritis or os...